Eizen Joshua M sold 2,826 shares of AN2 Therapeutics, Inc. at $4.22 for −$11.9k on Nov 5, 2026

Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
See Remarks
See Remarks
Filed Nov 6, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
−$11,925.72Shares × reported price
Shares traded
2,826Common Stock
Price per share
$4.22Reported price. Read footnotes for ranges.
% of reported position traded
1.34%This security and ownership context
Holdings after
207,546Direct
Trade date
Nov 5, 2026Sell
Filed
Nov 6, 2026, 6:20 PM ET1-day reporting delay
Accession
0001193125-26-452184Code S · Transaction 395299
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 210,372 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

No other transaction rows in this filing.

1 transaction row in this filing. Joint filers share the same rows.

ANTX price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
ANTX · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +27%1w ago +17%1d ago +6.3%
Returns since7d +14%30d90d180d1y

Footnotes in full

F1: Represents shares sold pursuant to the terms of the grant to satisfy tax withholding obligations arising from the vesting of Restricted Stock Units ("RSUs") on November 4, 2026. F2: Includes a balance of (a) 30,000 RSUs which vest as follows: 1/4th of the RSUs vest annually over four years from January 1, 2024, (b) 31,500 RSUs which vest as follows: 1/4th of the RSUs vest annually over four years from November 4, 2024, (c) 58,500 RSUs which vest as follows 1/4th of the RSUs vest annually over four years from January 1, 2025 and (d) 50,000 RSUs which vest as follows: 1/4th of RSUs vest annually over four years from January 1, 2026, in each case subject to the Reporting Person's continuous service as of such date. F3: Reflects the adjusted total which includes the purchase of 3,818 shares under the Issuer's 2022 Employee Stock Purchase Plan on September 30, 2026.